January 25, 2018 NIAID Funding News
Read this full issue online at http://www.niaid.nih.gov/
Learn your requirements and responsibilities if you want to use a subaward to augment your own expertise and improve the efficiency of your research.
Opportunities and Resources
The Innovation Corps is an eight-week, hands-on program that provides funding, mentoring, and networking opportunities to help active Phase I small business awardees commercialize promising biomedical technology.
In The News
To help researchers determine whether their proposed study is a clinical trial (CT), NIH revised its existing case studies and posted a few new ones to clarify how the CT definition does or doesn’t apply to certain types of studies.
NIH reissued the omnibus solicitations for small business grant applications. Sign up now to watch a pair of webinars that will review the changes that prompted the reissuance and how those differences may impact you.
NIH’s Next Generation Researchers Initiative working group will craft interim recommendations to be presented at the June 2018 Advisory Committee to the Director (ACD) meeting with final recommendations intended for the December 2018 ACD meeting.
The notice clarifies that underrepresentation may vary from setting to setting. The updated diversity statement is effective as of its release date, but it does not override diversity language in existing funding opportunity announcements.
Whether you are a peer reviewer, Advisory Council member, principal investigator, or someone named in a grant application or contract proposal, you must maintain integrity in the NIH peer review process.
NIAID and our research community offer our gratitude to those who have served as peer reviewers or on advisory committees.
- Can I watch the January NIAID Advisory Council meeting online?
- What constitutes research misconduct?
New Funding Opportunities
- PA-18-574, PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PA-18-575, PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
See other announcements at Opportunities & Announcements.
Send suggestions or comments to email@example.com.